Insider Transactions in Q2 2021 at Nevro Corp (NVRO)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Michael F Demane |
BUY
Grant, award, or other acquisition
|
Direct |
158
+0.07%
|
-
|
|
Jun 30
2021
|
Frank M Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
101
+0.25%
|
-
|
|
Jun 30
2021
|
Elizabeth H Weatherman |
BUY
Grant, award, or other acquisition
|
Direct |
119
+0.65%
|
-
|
|
Jun 22
2021
|
Michael F Demane |
SELL
Open market or private sale
|
Direct |
6,445
-2.71%
|
$1,153,655
$179.03 P/Share
|
|
Jun 19
2021
|
D Keith Grossman |
SELL
Payment of exercise price or tax liability
|
Direct |
4,874
-3.94%
|
$779,840
$160.45 P/Share
|
|
Jun 15
2021
|
Roderick H. Mac Leod SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,583
-7.66%
|
$250,114
$158.49 P/Share
|
|
Jun 04
2021
|
Kashif Rashid SVP, Corp Dev and CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
449
-1.28%
|
$66,452
$148.77 P/Share
|
|
May 25
2021
|
Elizabeth H Weatherman |
BUY
Grant, award, or other acquisition
|
Direct |
1,167
+6.08%
|
-
|
|
May 25
2021
|
Frank M Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
1,167
+2.78%
|
-
|
|
May 25
2021
|
Kevin C Oboyle |
BUY
Grant, award, or other acquisition
|
Direct |
1,167
+9.66%
|
-
|
|
May 25
2021
|
Karen Prange |
BUY
Grant, award, or other acquisition
|
Direct |
1,167
+23.17%
|
-
|
|
May 25
2021
|
Brad Vale Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,167
+12.46%
|
-
|
|
May 25
2021
|
Michael F Demane |
BUY
Grant, award, or other acquisition
|
Direct |
1,167
+0.49%
|
-
|
|
May 25
2021
|
Shawn Mc Cormick |
BUY
Grant, award, or other acquisition
|
Direct |
1,167
+12.13%
|
-
|
|
May 24
2021
|
Shawn Mc Cormick |
SELL
Open market or private sale
|
Direct |
482
-6.2%
|
$71,818
$149.65 P/Share
|
|
Apr 11
2021
|
D Keith Grossman |
SELL
Payment of exercise price or tax liability
|
Direct |
4,263
-3.33%
|
$626,661
$147.08 P/Share
|